GLP-1 Decision-Making Framework
CATAG developed this national decision-making framework to support the appropriate, equitable, and sustainable use of GLP-1 therapies for obesity in…
Designing a National Education Program to support quality use of medicines in Inflammatory Bowel Disease
The program aims to achieve better patient health outcomes, support optimal use of biological and small molecule medicines and contribute…